Some early-stage, low-risk breast cancer patients may not need radiotherapy after surgery

Some women with early-stage, low-risk breast cancer may not need radiotherapy after breast conserving surgery according to new research led by McMaster University, BC Cancer, Hamilton Heath Sciences, and the University of British Columbia.

Immunic Presents Data From Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Ulcerative Colitis at the United European Gastroenterology Week 2023 – Biotech Investments

Issuer: Immunic, Inc. / Key word(s): Conference/Study results 16.10.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Presents

October 17, 2023

Boehringer Ingelheim acquires Nerio Therapeutics for $1.3bn

The development of Nerio’s programme is the vital component of Boehringer’s immuno-oncology portfolio. Credit: BalkansCat / Shutterstock. Boehringer Ingelheim has acquired drug discovery and development

July 30, 2024

Dietary vitamin A shows promise in Alzheimer’s disease intervention, study finds

Study explored the impact of dietary vitamin A on gut microbiota and intestinal transcriptome, revealing its potential in Alzheimer’s disease (AD) pathology and cognitive functions

March 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.